The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors
Abstract
Tumor suppressor Pdcd4 has recently been shown to inhibit invasion by activating activator protein-1 (AP-1); however, little is known of the functionally significant Pdcd4-target genes. The urokinase receptor (u-PAR) promotes invasion/metastasis, and is associated with poor cancer-patient survival. The present study was conducted (1) to investigate a role for Pdcd4 in intravasation, invasion and u-PAR regulation, and (2) to describe mechanisms by which this is achieved. Fourteen cell lines showed reciprocal expression of u-PAR/Pdcd4. Resected tumor/normal tissues of 29 colorectal cancer patients demonstrated a significant inverse correlation between Pdcd4/u-PAR. siRNA-Pdcd4-transfected GEO cells significantly increased endogenous u-PAR mRNA/protein. A u-PAR-promoter-chloramphenicol acetyl transferase (CAT)-reporter was reduced in activity with increasing Pdcd4 expression in RKO. Deletion of a putative Sp-1-binding site (-402/-350) inhibited u-PAR promoter regulation by Pdcd4, this being paralleled by a reduction of Sp1 binding to this region in pdcd4-transfected cells. Pdcd4-transfected cells showed an increase in Sp3 binding to u-PAR promoter region -152/-135, the deletion of which reduces the ability of Pdcd4 to suppress u-PAR promoter activity. Surprisingly, the u-PAR-AP-1 site was not targeted by Pdcd4. Finally, RKO cells overexpressing Pdcd4 showed an inhibition of invasion/intravasation (chicken embryo metastasis assay). These data suggest Pdcd4 as a new negative regula…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It was shown that PDCD4 interacts with Sp1 and Sp3 inhibiting the u-PAR expression and tumor invasion/intravasion [39].”
From Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions (2019) · cites this paper as [39]
In the citing paper
“The anti-tumor activity of PDCD4 is well documented in invitro systems especially by using colon cancer cell lines [24,39]”
From Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions (2019) · cites this paper as [39]
Citations
Cites
A rapid in vitro assay for quantitating the invasive potential of tumor cells.
Albini, A., Iwamoto, Y., Hk, K., Gr, M., Aaronson, S. A., Jm, K., & McEwan, R. N. (1987) · PubMed · Cited by 1,769
Yang, H.-S., Jansen, A. P., Komar, A. A., Zheng, X., Merrick, W. C., Costes, S., Lockett, S. J., Sonenberg, N., & Colburn, N. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.26-37.2003 · Cited by 494
Self-citationKim, J., Yu, W., Kovalski, K., & Ossowski, L. (1998) · Cell · doi:10.1016/s0092-8674(00)81478-6 · Cited by 468
ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK)
Aguirre‐Ghiso, J. A., Estrada, Y. D., Liu, D., & Ossowski, L. (2004) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2003.12.012 · Cited by 465
Aguirre‐Ghiso, J. A., Liu, D., Mignatti, A., Kovalski, K., & Ossowski, L. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.4.863 · Cited by 447
Blasi, F. (1993) · BioEssays · doi:10.1002/bies.950150206 · Cited by 400
Jänicke, F., Schmitt, M., Pache, L., Ulm, K., Harbeck, N., Höfler, H., & Graeff, H. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf01833260 · Cited by 354
ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).
Aguirre‐Ghiso, J. A., Estrada, Y. D., Liu, D., & Ossowski, L. (2003) · PubMed · Cited by 350
O -linkage of N -acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability
Yang, X., Su, K., Roos, M. D., Chang, Q., Paterson, A. J., & Kudlow, J. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111099998 · Cited by 274
Qin, H., Sun, Y., & Benveniste, E. N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29130 · Cited by 271
Ossowski, L. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.107.6.2437 · Cited by 271
Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis
Chen, Y., Knösel, T., Kristiansen, G., Pietas, A., Garber, M. E., Matsuhashi, S., Ozaki, I., & Petersen, I. (2003) · The Journal of Pathology · doi:10.1002/path.1378 · Cited by 265
Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation
Cmarik, J. L., Min, H., Hegamyer, G., Zhan, S., Kulesz-Martin, M., Yoshinaga, H., Matsuhashi, S., & Colburn, N. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14037 · Cited by 254
Self-citationHeiss, M. M., Allgayer, H., Gruetzner, K. U., Funke, I., Babic, R., Jauch, K., & Schildberg, F. W. (1995) · Nature Medicine · doi:10.1038/nm1095-1035 · Cited by 252
Self-citationIsolation of a novel mouse gene MA-3 that is induced upon programmed cell death
Shibahara, K., Asano, M., Ishida, Y., Aoki, T., Koike, T., & Honjo, T. (1995) · Gene · doi:10.1016/0378-1119(95)00607-9 · Cited by 223
Epidermal Expression of the Translation Inhibitor Programmed Cell Death 4 Suppresses Tumorigenesis
Jansen, A. P., Camalier, C. E., & Colburn, N. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2119 · Cited by 212
Self-citationZijlstra, A., Mellor, R. L., Panzarella, G., Aimes, R. T., Hooper, J. D., Marchenko, N. D., & Quigley, J. P. (2002) · PubMed · Cited by 207
In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.
Ossowski, L., Clunie, G. J. A., Masucci, M. T., & Blasi, F. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.115.4.1107 · Cited by 206
Yang, H.-S., Matthews, C. P., Clair, T., Wang, Q., Baker, A. R., Li, C.-C. H., Tan, T.-H., & Colburn, N. H. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1297-1306.2006 · Cited by 202
Self-citationNekarda, H., Schmitt, M., Ulm, K., Wenninger, A., Vogelsang, H., Becker, K., Roder, J. D., Fink, U., & Siewert, J. R. (1994) · PubMed · Cited by 201
Yang, H.-S., Cho, M.-H., Zakowicz, H., Hegamyer, G., Sonenberg, N., & Colburn, N. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.9.3894-3906.2004 · Cited by 199
Self-citationYang, H.-S., Jansen, A. P., Nair, R., Shibahara, K., Verma, A. K., Cmarik, J. L., & Colburn, N. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204137 · Cited by 185
Self-citationUrokinase receptor and colorectal cancer survival
Ganesh, S. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91427-3 · Cited by 164
Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation
Yang, H.-S., Knies, J. L., Stark, C., & Colburn, N. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206433 · Cited by 160
Self-citationAkt Phosphorylates and Regulates Pdcd4 Tumor Suppressor Protein
Palamarchuk, A., Efanov, A., Maximov, V., Aqeilan, R. I., Croce, C. M., & Pekarsky, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-3469 · Cited by 151
Shc Binding to Nerve Growth Factor Receptor Is Mediated by the Phosphotyrosine Interaction Domain
Đikić, I., Batzer, A., Blaikie, P., Obermeier, A., Ullrich, A., Schlessinger, J., & Margolis, B. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15125 · Cited by 145
Bitomsky, N., Böhm, M., & Klempnauer, K.-H. (2004) · Oncogene · doi:10.1038/sj.onc.1208064 · Cited by 134
Jansen, A. P., Camalier, C. E., Stark, C., & Colburn, N. H. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.103.3.2 · Cited by 132
Self-citationDetermination of the levels of urokinase and its receptor in human colon carcinoma cell lines.
Boyd, D. D., Florent, G., Kim, P., & Brattain, M. G. (1988) · PubMed · Cited by 128
(2003) · Current Problems in Cancer · doi:10.1016/s0147-0272(03)00106-5 · Cited by 126
Azzoni, L., Zatsepina, O., Abebe, B., Bennett, I. M., Kanakaraj, P., & Perussia, B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3493 · Cited by 105
An N-terminal Region of Sp1 Targets Its Proteasome-dependent Degradation in Vitro
Su, K., Roos, M. D., Yang, X., Han, I., Paterson, A. J., & Kudlow, J. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15194 · Cited by 105
Shetty, S., Kumar, A., & Idell, S. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1075 · Cited by 104
Zhang, Z., & DuBois, R. N. (2001) · Oncogene · doi:10.1038/sj.onc.1204588 · Cited by 90
Lengyel, E. R., Wang, H., Stepp, E., Juarez, J., Wang, Y., Doe, W. F., Pfarr, C. M., & Boyd, D. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23176 · Cited by 81
Ahmed, N., Oliva, K., Wang, Y., Quinn, M. A., & Rice, G. E. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601098 · Cited by 80
Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II
Lankat–Buttgereit, B., Gregel, C. M., Knolle, A., Hasilík, A., Arnold, R., & Göke, R. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.058 · Cited by 75
Transcriptional Induction of the Urokinase Receptor Gene by a Constitutively Active Src
Allgayer, H., Wang, H., Gallick, G. E., Crabtree, A., Mazar, A. P., Jones, T. R., Kraker, A. J., & Boyd, D. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18428 · Cited by 72
Self-citationRitchie, S. A., Boyd, M., Wong, J. W. H., & Bonham, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.847 · Cited by 68
Wang, Y., Dang, J., Wang, H., Allgayer, H., Murrell, G. A. C., & Boyd, D. D. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01350.x · Cited by 67
Self-citationDo proteases play a role in cancer invasion and metastasis?
Duffy, M. J. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90326-9 · Cited by 67
Schmitt, M., Magdolen, V., Sperl, S., Muehlenweg, B., & Harbeck, N. (2001) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.1.4.683 · Cited by 63
Yoshinaga, H., Matsuhashi, S., Fujiyama, C., & Masaki, Z. (1999) · Pathology International · doi:10.1046/j.1440-1827.1999.00995.x · Cited by 62
Zakowicz, H., Yang, H., Stark, C., Wlodawer, A., LaRonde-LeBlanc, N. A., & Colburn, N. H. (2005) · RNA · doi:10.1261/rna.7191905 · Cited by 60
Self-citationUp-regulation of PDCD4 in senescent human diploid fibroblasts
Kang, M.-J., Ahn, H.-S., Lee, J.-Y., Matsuhashi, S., & Park, W.-Y. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00264-4 · Cited by 57
Allgayer, H., Wang, H., Shirasawa, S., Sasazuki, T., & Boyd, D. D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690616 · Cited by 54
Self-citationThe chicken Pdcd4 gene is regulated by v-Myb
Schlichter, U. H. A., Burk, O., Worpenberg, S., & Klempnauer, K.-H. (2001) · Oncogene · doi:10.1038/sj.onc.1204071 · Cited by 53
Hapke, S., Gawaz, M., Dehne, K., Köhler, J., Marshall, J. F., Graeff, H., Schmitt, M., Reuning, U., & Lengyel, E. R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2118-2132.2001 · Cited by 49
Programmed Cell Death Protein 4 (PDCD4) Acts As a Tumor Suppressor in Neuroendocrine Tumor Cells
Göke, R., Gregel, C. M., Göke, A., Arnold, R., Schmidt, H., & Lankat–Buttgereit, B. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.024 · Cited by 49
Cloning of the TIS gene suppressed by topoisomerase inhibitors
Onishi, Y., Hashimoto, S., & Kizaki, H. (1998) · Gene · doi:10.1016/s0378-1119(98)00313-8 · Cited by 47
Soejima, H., Miyoshi, O., Yoshinaga, H., Masaki, Z., Ozaki, I., Kajiwara, S., Niikawa, N., Matsuhashi, S., & Mukai, T. (1999) · Cytogenetic and Genome Research · doi:10.1159/000015408 · Cited by 43
Allgayer, H., Wang, H., Wang, Y., Heiss, M. M., Bauer, R., Nyormoi, O., & Boyd, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4702 · Cited by 41
Self-citationTranscriptional activation of the urokinase receptor gene in invasive colon cancer
Wang, H., Skibber, J. M., Juarez, J., & Boyd, D. D. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580506 · Cited by 40
Regulation of Urokinase Receptor Expression by Phosphoglycerate Kinase
Shetty, S., Muniyappa, H., Halady, P. K. S., & Idell, S. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0104oc · Cited by 38
Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma.
Wagner, S. N., Atkinson, M. J., THANNER, S., Wagner, C., Schmitt, M., Wilhelm, O. G., Rotter, M., & Höfler, H. (1995) · Europe PMC (PubMed Central) · Cited by 35
Molecular Cloning of the Genes Suppressed in RVC Lymphoma Cells by Topoisomerase Inhibitors
Onishi, Y., & Kizaki, H. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1609 · Cited by 34
Schewe, D. M., Biller, T., Maurer, G. D., Asangani, I. A., Leupold, J. H., Lengyel, E. R., Post, S., & Allgayer, H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0786 · Cited by 30
Self-citationATP Luminescence-Based Motility-Invasion Assay
de la Monte, S. M., Lahousse, S. A., Carter, J., & Wands, J. R. (2002) · BioTechniques · doi:10.2144/02331rr01 · Cited by 30
The biology of colorectal carcinoma
Jessup, J. M., & Gallich, G. E. (1992) · Current Problems in Cancer · doi:10.1016/0147-0272(92)90049-t · Cited by 28
Heiss, M. M., Babic, R., Allgayer, H., Gruetzner, K. U., Jauch, K.-W., Loehrs, U., & Schildberg, F. W. (1996) · European Journal of Surgical Oncology · doi:10.1016/s0748-7983(96)91649-2 · Cited by 27
Self-citationFuchs, T., & Allgayer, H. (2003) · Biological Chemistry · doi:10.1515/bc.2003.084 · Cited by 16
Self-citationStalberg, P. L. H., Lopez-Egido, J. R., Wang, S., Gobl, A., Öberg, K., & Skogseid, B. M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4329 · Cited by 13
Boyd, D. D., & Brattain, M. G. (1989) · PubMed · Cited by 13
Research works printed but not linked: 1
- Aguirre-Ghiso J, Estrada Y, Liu D, Ossowski L . (2003). ERKMAPK activity as a determinant of tumor growth and dormancy; regulation by p38SAPK. Cancer Res 63: 1684–1695.
Cited by
Sorted by citations
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882
Self-citationMicroRNA: Biogenesis, Function and Role in Cancer
MacFarlane, L.-A., & R. Murphy, P. (2010) · Current Genomics · doi:10.2174/138920210793175895 · Cited by 1,584
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S., & Mo, Y.-Y. (2008) · Cell Research · doi:10.1038/cr.2008.24 · Cited by 1,051
miR‐21: a small multi‐faceted RNA
Krichevsky, A. M., & Gabriely, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00556.x · Cited by 987
Potential anticancer properties and mechanisms of action of curcumin.
Vallianou, N. G., Evangelopoulos, A. A., Schizas, N., & Kazazis, C. E. (2015) · PubMed · Cited by 333
Metadata
- Authors
- Leupold, J. H., Yang, H.-S., Colburn, N. H., Asangani, I., Post, S., & Allgayer, H.
- Affiliations
- German Cancer Research Center (DE)
- National Institutes of Health (US)
- Heidelberg University (DE)
- Corresponding author
- Allgayer, H
- Venue
- Oncogene
- Published
- 2007-02-12
- Volume
- 26
- Issue
- 31
- Pages
- 4550-4562
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2038623184
- Cited by
- 163
- References
- 64
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 13 · 2015: 8 · 2014: 18 · 2013: 15 · 2012: 11
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- PDCD4, tumor suppressor, urokinase receptor, Sp1, Sp3, transcriptional regulation, tumor invasion, intravasation, colorectal cancer, metastasis, activator protein-1
- MeSH terms
- Binding Sites, Humans, Neoplasm Invasiveness, Neoplasm Metastasis, Receptors, Cell Surface, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Sp1 Transcription Factor, RNA-Binding Proteins, Disease Progression, Tumor Suppressor Proteins, Cell Line, Tumor, Apoptosis Regulatory Proteins, Sp Transcription Factors, Sp3 Transcription Factor, Receptors, Urokinase Plasminogen Activator
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review